Article
The miRNA 196a2 rs11614913 variant has prognostic impact on Turkish patients with multiple myeloma.
BMC research notes - 23 Nov 2020
Kirik Melya Pelin, Pehlivan Mustafa, Nursal Ayse Feyda, Oyaci Yasemin, Pehlivan Sacide, Serin Istemi
Abstract excerpt
OBJECTIVE: Multiple myeloma (MM) arises from malignant plasma cells as a single clone in the bone marrow. Accumulating evidences have reported that there is an association between miR-196a2 (rs11614913) variant and various cancers while there were unverified and inconsistent results in MM. The goal of this study is to investigate the impact of the miR-196a2 variant on clinical findings and susceptibility in MM....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
